The abstract is read at the publisher; the summary is JClub's.
Alpha-synuclein seeding activity in olfactory mucosa is detected far more often in Parkinson’s disease than after SARS-CoV-2 infection or in healthy controls (80.4% vs 24.2% vs 11.9%).
- Why it matters: It addresses whether SARS-CoV-2 infection is linked to local α-synuclein misfolding in the olfactory mucosa, a potential mechanism behind persistent olfactory dysfunction.
- What they did: In an observational pilot study, olfactory mucosa samples from PD (n = 51), post-COVID participants (n = 95; COVID+OD n = 42, COVID-OD n = 53), and healthy controls (n = 42) were tested by α-synuclein seeding-amplification assays at the University of Verona.
- The result: Post-COVID positivity is higher with persistent olfactory dysfunction (35.7% vs 15.1%; p = 0.030), and within post-COVID, positivity associates with lower SSI (p = 0.007) and SSD (p < 0.001), but not with MDS-UPDRS, MoCA, or RBD measures.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.